Cargando…
IA方案和HAD方案诱导治疗FLT3-ITD突变阳性急性髓系白血病疗效比较
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343015/ https://www.ncbi.nlm.nih.gov/pubmed/31104447 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.04.013 |
_version_ | 1783555669277802496 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7343015 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Editorial office of Chinese Journal of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-73430152020-07-16 IA方案和HAD方案诱导治疗FLT3-ITD突变阳性急性髓系白血病疗效比较 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2019-04 /pmc/articles/PMC7343015/ /pubmed/31104447 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.04.013 Text en 2019年版权归中华医学会所有 http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution 3.0 License (CC-BY-NC). The Copyright own by Publisher. Without authorization, shall not reprint, except this publication article, shall not use this publication format design. Unless otherwise stated, all articles published in this journal do not represent the views of the Chinese Medical Association or the editorial board of this journal. |
spellingShingle | 短篇论著 IA方案和HAD方案诱导治疗FLT3-ITD突变阳性急性髓系白血病疗效比较 |
title | IA方案和HAD方案诱导治疗FLT3-ITD突变阳性急性髓系白血病疗效比较 |
title_full | IA方案和HAD方案诱导治疗FLT3-ITD突变阳性急性髓系白血病疗效比较 |
title_fullStr | IA方案和HAD方案诱导治疗FLT3-ITD突变阳性急性髓系白血病疗效比较 |
title_full_unstemmed | IA方案和HAD方案诱导治疗FLT3-ITD突变阳性急性髓系白血病疗效比较 |
title_short | IA方案和HAD方案诱导治疗FLT3-ITD突变阳性急性髓系白血病疗效比较 |
title_sort | ia方案和had方案诱导治疗flt3-itd突变阳性急性髓系白血病疗效比较 |
topic | 短篇论著 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343015/ https://www.ncbi.nlm.nih.gov/pubmed/31104447 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.04.013 |
work_keys_str_mv | AT iafāngànhéhadfāngànyòudǎozhìliáoflt3itdtūbiànyángxìngjíxìngsuǐxìbáixuèbìngliáoxiàobǐjiào AT iafāngànhéhadfāngànyòudǎozhìliáoflt3itdtūbiànyángxìngjíxìngsuǐxìbáixuèbìngliáoxiàobǐjiào AT iafāngànhéhadfāngànyòudǎozhìliáoflt3itdtūbiànyángxìngjíxìngsuǐxìbáixuèbìngliáoxiàobǐjiào AT iafāngànhéhadfāngànyòudǎozhìliáoflt3itdtūbiànyángxìngjíxìngsuǐxìbáixuèbìngliáoxiàobǐjiào AT iafāngànhéhadfāngànyòudǎozhìliáoflt3itdtūbiànyángxìngjíxìngsuǐxìbáixuèbìngliáoxiàobǐjiào AT iafāngànhéhadfāngànyòudǎozhìliáoflt3itdtūbiànyángxìngjíxìngsuǐxìbáixuèbìngliáoxiàobǐjiào |